Laserfiche WebLink
DocuSign Envelope ID:COA2C376-DO83-4406-8D6C-OA6C2103A7F3 <br /> Timeline <br /> The program is scheduled from April 2024 to April 2025, with the possibility of extension based <br /> on additional fund allocations. <br /> Performance Measures <br /> - Monitoring the number of residents benefiting from MAT. <br /> - Tracking the engagement of healthcare providers in opioid prescription training. <br /> - Reporting on the reach and impact of Naloxone training sessions. <br /> - Documenting the scope of fentanyl education initiatives. <br /> - Assessing the participation in Texas State University collaboration events. <br /> - Evaluating the effectiveness of media campaigns on opioid misuse prevention. <br />